Blue Trust Inc’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-63
Closed -$1.29K – 2626
2026
Q2
$1.29K Hold
63
– – ﹤0.01% 2256
2026
Q1
$1K Buy
+63
New +$1.37K ﹤0.01% 2260
2025
Q4
– Sell
-12
Closed -$271 – 2596
2025
Q3
$271 Hold
12
– – ﹤0.01% 2494
2025
Q2
$239 Hold
12
– – ﹤0.01% 2373
2025
Q1
$203 Hold
12
– – ﹤0.01% 2420
2024
Q4
$222 Sell
12
-85
-88% -$1.66K ﹤0.01% 2380
2024
Q3
$1.9K Sell
97
-179
-65% -$4K ﹤0.01% 2591
2024
Q2
$5.99K Buy
+276
New +$5.76K ﹤0.01% 2128
2024
Q1
– Sell
-82
Closed -$2K – 2368
2023
Q4
$2K Buy
+82
New +$2.19K ﹤0.01% 2137
2023
Q2
– Sell
-236
Closed -$7K – 2185
2023
Q1
$7K Sell
236
-94
-28% -$3.02K ﹤0.01% 1688
2022
Q4
$12K Sell
330
-277
-46% -$9.91K ﹤0.01% 1471
2022
Q3
$33K Buy
607
+557
+1,114% +$27.9K ﹤0.01% 899
2022
Q2
$3K Buy
+50
New +$2.75K ﹤0.01% 1568

Other funds holding FLGT

Blue Trust Inc's FLGT Position: Q3 2026 in Review

Blue Trust Inc sold out of Fulgent Genetics (FLGT) in Q3 2026, closing a stake of 63 shares — an estimated $1.29K sold.

Blue Trust Inc first reported a position in FLGT in Q2 2022 and held it in 13 quarters. The position peaked at $33K in Q3 2022. 10 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Blue Trust Inc reported no remaining Fulgent Genetics position as of Q3 2026 after selling out during the quarter.
  • Blue Trust Inc sold 63 Fulgent Genetics shares in Q3 2026, an estimated $1.29K.
  • Blue Trust Inc first reported a position in Fulgent Genetics in Q2 2022 and held it in 13 quarters.
  • Blue Trust Inc's Fulgent Genetics position peaked at $33K in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.